# TIVICAY PD
> **NDA213983** · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2020-06-12
## Drug
- **FDA Application Number:** NDA213983
- **Application type:** New Drug Application
- **Brand name:** TIVICAY PD
- **Generic name:** DOLUTEGRAVIR SODIUM
- **Active ingredients:** DOLUTEGRAVIR SODIUM
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VIIV HLTHCARE
- **Manufacturer:** ViiV Healthcare Company
- **First approval:** 2020-06-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213983)
---
*AI Analytics · CC0 1.0*